Our studies further identify a group of genes previously implicated in metastasis, whose opposing regulatory control by KDM5A/PHF2 and EWS/Fli1 may importantly contribute to modulation of Ewing sarcoma metastatic potency. This evidence concerns the gene PHF2 and Ewing sarcoma.